to 1 M. Purified STxB was tagged with AlexaFluor-488 (Invitrogen, Carlsbad, CA) or Cy3 (GE Healthcare) using manufacturer's protocols. Fluorescently-tagged STxB-KDEL was a gift of Dr. Ludger Johannes, Institut Curie, Paris.
STxB transport assay. Transport of STxB was assayed essentially as described (10) . Levels of Gb3 synthase vary in HeLa cells and uptake of STxB is directly dependent on Gb3 synthase expression (18) . To ensure uniform uptake of STxB in all control and Mntreated cells, cultures were transfected with the untagged Gb3 synthase plasmid 2 days prior to use in the transport assay. For assays to compare the effect of Mn, cultures were treated with or without 500 µM Mn for 4 h, then washed 3 times in ice-cold phosphate buffer saline (PBS), incubated with 2.5 µg/ ml of fluorescent STxB in MEM at 4ºC for 30 min, washed 3 more times in cold PBS and transferred to regular medium at 37ºC with or without 500 µM Mn for indicated times. Cultures were then fixed using paraformaldehyde (3%) and processed for immunofluorescence staining.
To assess overlap of STxB with Rab5 or Rab7, GFP-tagged Rab constructs were co-transfected with untagged Gb3 synthase 2 days prior to performing the transport assay. The level of co-transfection, under our conditions, is at least 98% (6). The transport assay was then performed with 4 h 500 µM Mn pre-treatment as described above.
To simultaneously analyze transport of EGF and STxB, Mn treated and control cells were incubated with 2.5 µg/ml of fluorescent EGF along with 2.5 µg/ml of STxB in MEM at 4ºC for 30 min and then shifted to 37ºC for indicated times.
To determine if expression of GPP130 constructs could rescue STxB trafficking, cells were co-transfected with untagged Gb3 synthase and the indicated GPP130-GFP plasmids 2 days prior to the transport assay, treated with 500 µM Mn for 4 h followed by the transport assay.
Transport of STxB in GPP130 knockdown cultures was performed as described above with the exception that cultures were transfected with untagged Gb3 synthase DNA construct 24 h after transfection with anti-GPP130 or control siRNA. STxB transport was analyzed 48 h after DNA transfection.
Manipulations required to synchronize STxB and GPP130 transport are described in Fig.S9 and the STxB degradation assay is described below.
CTxB transport assay. To analyze transport of fluorescently labeled CTxB (Invitrogen) HeLa cells treated with or without 500 µM for 4 h were washed 3 times in cold PBS, incubated with 7 µg/ ml CTxB in MEM at 4ºC for 30 min, washed 3 more times in cold PBS, transferred to regular medium with or without Mn for the times indicated, fixed and stained.
EGF degradation assay. The EGF degradation assay was performed as described (5) . HeLa cells were transfected with GFP-tagged Rab5 and used for the assay one day after transfection. Rab5 was used as a control to ensure that Mn did not affect integrity of the endosomal compartment in general. Cells were treated with or without 500 µM Mn for 4 h, loaded with EGF tagged with Alexa Fluor 568 (Invitrogen) for 60 min at 37°C and then washed and chased for 60 min at 37°C in EGF-free medium with and without 500 µM Mn. At the end of the chase, cells were permeabilized with PBS containing 0.03% saponin and 2% bovine serum albumin at room temperature for 5 min. The Alexa Fluor dye is not degraded by lysosomal hydrolases and persists even after degradation of EGF itself. The saponin permeabilization before fixation releases the free Alexa tag from the cell without affecting undegraded Alexa Fluor-EGF complexes. After permeabilization, cells were fixed with 3% PFA and mounted for microscopy.
STxB degradation assay. The EGF degradation assay was modified to analyze loss of STxB over time. Briefly, cells were transfected either with GFP-tagged Gb3 synthase or co-transfected with untagged Gb3 synthase and GFP-tagged dominant negative Rab7 (Rab7-T22N). Two days post transfection, cultures were treated with or without 500 µM Mn for 4 h and the STxB transport assay was performed using Cy3-tagged STxB exactly as described above. At the end of the assay but prior to fixation, cells were permeabilized using PBS containing 0.03% saponin and 2% bovine serum albumin at room temperature for 5 min. This was done to ensure release of free Cy3 dye no longer covalently attached to degraded STxB without affecting undegraded STxB-Cy3 complexes. Cultures were then fixed and processed for microscopy. Only GFP-positive cells were used for analysis.
VSVG-GFP transport assay. Anterograde transport of GFP-tagged vesicular stomatis virus G protein was analyzed as described (6) . 500 µM Mn was added for 4 h at 40ºC and was present during the temperature shift at 32ºC. The monoclonal antibody against VSVG (28) was a gift of Dr. Ora Weisz, University of Pittsburgh.
Protein Binding Assays. GST-tagged GPP130 constructs, GST-only control and Histagged STxB were bacterially purified using standard methods (29) . GST-proteins were dialyzed into PBS; pH 7.4. His-tagged STxB was eluted in 50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, 0.1% β-mercaptoethanol. The pH of the eluted His-STxB was adjusted to 7.4 using 1.7 µl concentrated HCl per 100 µl elute. Binding assays were performed in 100 µl reactions in PBS with 0.1% Triton X-100. Indicated molar amounts of GST proteins and 0.4 µM His-STxB were used. For the His-protein, we needed 2.5 µg of protein for the 100 µl reaction to get the required molar amount and this was achieved by adding 5 µl of a concentrated stock. GST-proteins and STxB were mixed and incubated at 4ºC for 1 h with constant rotation followed by addition of 5 µl of glutathione agarose beads for another hour. Beads were then recovered by pulse spin, rapidly washed 2 times with PBS+0.01% Triton X-100 and once with PBS only, resuspended in reducing sample buffer and analyzed by SDS-PAGE and Coomassie staining.
STx1 cytotoxicity assays.
MTT assay. In order to obtain the same number of cells competent to internalize STx1 for the viability assays, cells were transfected with GFP-tagged Gb3 synthase and, after one day, 10,000 GFP-positive cells were sorted into wells of a 24-well plate using fluorescence activated cell sorting (Vantage SF; Becton Dickinson). After 24 h, the cells were treated with or without 500 µM Mn for 4 h and then exposed to the indicated concentrations of STx1 (ListLabs, Campbell, CA) for 24 h. Level of Mn was reduced to 125 µM during this phase. At the end of the experiment, viability was assessed using methylthiazolylphenyl-tetrazolium bromide (MTT; EMD Chemicals Gibbstown, NJ) (5, 6) . For this, cells were washed with Hanks balanced salt solution (Sigma, St.
Louis, MO), adjusted to 0.05% MTT (wt/vol) in Hanks balanced Salt solution for 2 h at 37°C and lysed using 500 µl of 0.1 N hydrochloric acid in isopropanol and 1% Triton X-100. Absorption was subsequently measured at 570 nm. This experiment was replicated 3 times with each point in each experiment determine in triplicate.
Propidium iodide assay. For propidium iodide staining cells were transfected with GFP-Gb3 synthase as described above, treated with or without 500 µM Mn for 4 h and subsequently exposed to 0 or 100 ng/ml STx1 for 24 h. Mn was reduced to 125 µM during this phase. Cells were then washed two times in binding buffer (10 mM Hepes; pH 7.4, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , and 1.8 mM CaCl 2 ), incubated in 1% propidium iodide in binding buffer for 15 min at room temperature, washed again in binding buffer and immediately processed for microscopy.
Animal studies. Animal handling was done according to protocols approved by the Institutional Animal Care and Use Committee of Carnegie Mellon University. All experiments were performed using male BABL/c mice aged 39-49 days purchased from Charles River (Wilmington, MA) and used 2 days after receipt.
Mn LD50. To determine the LD50 of Mn, mice (n=4 per dose) were given a single intraperitoneal injection of 0, 1, 10, 25, 50, 100, 150, 250 or 500 mg/kg MnCl 2 in 0.5 ml autoclaved water. Survival was monitored for a week. Animals injected with 250 and 500 mg/kg Mn got paralyzed within minutes and died. Those injected with 150 mg/kg got paralyzed within a few hours and were then euthanized. Paralysis and lethality were not seen at any time with doses of 100 mg/kg and lower.
Mn toxicity and body weight. Mice received daily intraperitoneal injections of 0, 1, 10, 25, 50 and 100 mg/kg of MnCl 2 in 0.2 ml autoclaved water (n=4 for each dose except n=2 for the 100 mg/kg dose) for 4 days. Survival, body weight, locomotor activity and general demeanor was monitored every 12 h. Mice injected with 100 mg/kg significantly lost weight, exhibited a depressed, lethargic attitude accompanied with diminished locomotor activity. Doses up to 50 mg/kg did not cause a reduction in body weight or locomotion or induce any other behavioral defects or systemic signs and symptoms.
Protective effect of Mn on STx1. STx1 (25 µg/kg in 0.2 ml PBS) was injected intraperitoneally (~500 ng/mouse). Five animals received only STx1, the others were pre-treated with Mn. For the protection regimen, animals received daily intraperitoneal injections of Mn beginning 5 days prior to STx1 exposure. Mn injections continued on the day of and on days following STx1 injection. Doses of Mn tested were 1, 10, 25 and 50 mg/kg (n=6 for 50 mg/kg, n=4 for all other doses, the 50 mg/kg dose was reduced to 25 mg/kg after STx1 injection). All Mn injections were in 0.2 ml autoclaved water. After STx1 injections, survival was monitored every 8 h for 8 days. At the end of the experiment, animals were deeply anesthetized with ketamine; kidneys were rapidly dissected, immersed in 4% paraformaldehyde and stored at 4ºC. For histopathological and ultrastructural analyses, renal tissue was embedded in LR White or Epoxy resin and sectioned using a Reichert-Jung ultramicrotome. Thick sections (1.5µm) were cut with a glass knife, and were stained with a 1% toluidine blue stain. Thin sections (100nm) were cut with a diamond knife, and were stained with uranyl acetate and lead citrate. Electron microscopy was performed using a H-7100 transmission electron microscope (Hitachi High Technologies America, Pleasanton, CA) operating at 75 kV and images were obtained using an AMT Advantage 10 charge-coupled device Camera System (Advanced Microscopy Techniques, Danvers, MA). Toluidine blue staining was detected using Ph2 Plan-Neofluor 20×/0.5 NA objective on an Axioplan microscope (Carl Zeiss) and acquired with QED software and a 12-bit Orca ER digital camera (Hamamatsu Photonics).
Image analysis. Immunofluorescence images were analyzed using ImageJ (http://rsbweb.nih.gov/ij) essentially as described (5, 6) . For all fluorescence measurements in cells, average value projections were created from individual Z-stacks and background was subtracted for each image separately. To determine the mean fluorescence per cell for EGF, STxB, CTxB and VSVG staining, the cells were outlined and analyzed using the Analyze Particles and Measure functions in ImageJ. To calculate percent cellular STxB and CTxB in the Golgi, giantin staining was used to demarcate the Golgi and the amount in the Golgi was compared to total cellular fluorescence using Analyze Particles and Measure. To determine number of GP73, TGN46 and Lamp2 endosomes per cell, images were uniformly thresholded and endosomes counted using Analyze Particles. To calculate the number of STxB, CTxB and EGF endosomes with tubules, between 100-150 endosomes per cell were analyzed using a drawn grid to score the presence or absence of a tubular projection of at least 0.2 µm.
Statistical analyses. All findings presented have been replicated in three or more independent experiments. Statistical analyses were performed using Prism 5 software (GraphPad Software Inc., La Jolla, CA). Comparisons between two groups were performed using two-tailed Student's t test assuming equal variances. Multiple group comparison at the same time was done using single-factor analysis of variance (ANOVA) with the Tukey-Kramer post hoc test. Non-linear regression analyses were performed using best-fit equations from Prism. Survival fractions were calculated using the method of Kaplan-Meier. Survival curves were compared using the log rank and Gehan-BreslowWilcoxon tests. In general, p < 0.05 was considered significant and the determined p values are provided in the figure legends. Asterisks (*) in graphs, wherever present, denote statistically significant differences.
Fig. S1. Mn blocks retrograde trafficking of STxB-KDEL.
A. HeLa cells were treated with 500 µM Mn for 4 h or left untreated. The STxB transport assay was then performed using STxB-KDEL. Bar, 10 µm. B. Quantitation of data from Panel A (mean±SE; n=3 with 100-150 cells per experiment; * p < 0.05 for the difference between control and Mn-treated cells with ER-localized STxB at 60 min). In controls, percent cells with ER-localized STxB-KDEL is 60% at the 1 h time point and approaches 100% by 4 h. STxB is degraded in Mn-treated cells between 1-2 h (see Fig. 2D ), hence the 1 h time point was used for the assay. 
Fig. S4. Mn does not affect VSVG trafficking.
A. The VSVG transport assay was performed in HeLa cells treated with or without 500 µM Mn for 4 h. Cells were labeled to detect surface VSVG-GFP using a monoclonal antibody. Bar, 10 µm. B. VSVG-GFP transport assay was performed as described for Panel A and cells were imaged to detect giantin and VSVG-GFP. Bar, 10 µm. C. Ratio of surface to total VSVG per cell at times after temperature shift from Panel A above (mean±SE; 15 cells per point).
Fig. S5. Mn does not affect trafficking of GP73, TGN46 and Lamp2.
A. HeLa cells were left untreated or exposed to 500 µM Mn for 4 h and then further treated with or without 10 µM monensin for 1 h. Monensin blocks endosome-to-Golgi trafficking causing endosomal redistribution of GP73 and TGN46 as they constitutively cycle between endosomes and the Golgi (8) . Cultures were stained to detect GP73 and giantin, a Golgi-localized protein that does not traffic to endosomes. Note that siRNAmediated depletion of GPP130 causes redistribution of GP73 to endosomes (9) . The discrepancy between Mn and siRNA could be due to residual GPP130 after Mn or offtarget effects of the siRNAs previously used. Graph depicts GP73 endosomes per cell (mean±SE; n=15 cells per group). Bar, 10 µm. B. HeLa cells were transfected with a GFP-tagged TGN46 and two days later treated with Mn and monensin as in Panel A. Cells were imaged to detect TGN46 and giantin. Graph depicts TGN46 endosomes per cell (mean±SE; n=15 cells per group). Bar, 10 µm. C. HeLa cells were treated with 500 µM Mn for 4 h and stained to detect Lamp2, a protein that traffics to lysosomes from the Golgi, and giantin. Graph depicts Lamp2 endosomes per cell (mean±SE; n=15 cells per group). Bar, 10 µm.
Fig. S6. Mn does not affect Rab5 and Rab7 distribution.
Cells were transfected with Rab5 or Rab7-GFP, treated with 500 µM Mn for 4 h and then imaged to detect GFP and early endosome antigen 1, a marker for early endosomes. As expected, Rab5, but not Rab7, overlapped with early endosome antigen 1 (arrowheads). Thus, in Mn-treated cells, Rab5 maintains its early endosomal localization and Rab7 is not redistributed to early endosomes. Bar, 10 µm. Cells were treated with or without 500 µM Mn for 4 h. The STxB transport assay was then performed and cellular STxB levels were assessed at the indicated times as described in Methods. Transfection of GFP-tagged dominant negative (DN) version of Rab7 (Rab7-T22N) was performed two days prior to Mn treatment. Every cell analyzed expressed Gb3-synthase, the enzyme that synthesizes the plasma membrane STxB receptor. Quantitation is in Fig. 2D . Note that degradation of STxB began after a lag of 54 min, which is consistent with the time required to reach degradative compartments and fit a single phase exponential decay with a t 1/2 of 14 min resulting in >90% loss of total STxB within one hour and 40 min. Bar, 10 µm. GPP130 is a single pass transmembrane protein with a short cytoplasmic domain (CYTO; residues 1-12), a single transmembrane domain (TMD; residues 13-35) and a long lumenal domain (residues 36-696). The lumenal domain is subdivided into a predicted coiled-coil stem domain (residues 36-245) and an acidic C-terminus (residues 246-696). The stem domain of GPP130 can be further subdivided at predicted breaks in the coil. Residues 36-87 (G1) and 176-245 (G2) independently confer Golgi localization to GPP130 while residues 88-175 (E) mediate endosome-to-Golgi trafficking. Positions of green fluorescent protein (GFP) or glutathione S-transferase (GST) tags are indicated. Figure S15 . Mn and monensinsensitivity of GFP-tagged GPP130 constructs used in the study. HeLa cells were transfected with indicated GFP-tagged GPP130 constructs. One day later, the cells were exposed to 500 µM Mn for 4 h and then, in the continued presence of Mn, they were left untreated (Ø), treated with 10 µm monensin for 1 h (Monensin), or treated with 10 µm monensin for 1 h followed by a washout incubation for a further 3 h (W/O). Cultures were imaged to detect GFP and giantin. Bar, 10 µm.
Fig. S16. Schematic model.
In control cells (-Mn), the Golgi-to-endosome cycling of GPP130 is depicted in blue and the GPP130-dependent retrograde trafficking of STx is depicted in red. Manganese addition (+Mn) diverts GPP130 to lysosomes leaving STx no receptor for sorting into Golgi-directed endosome tubules. Consequently, STx is degraded in lysosomes. A. Cells expressing GFP-Gb3 synthase were treated with or without 500 µM Mn for 4 h followed by exposure to 0 or 100 ng/ml STx1 for 24 h. During the STx1 treatment Mn was reduced to 125 µM. Viability of GFP-positive cells was then assessed using propidium iodide staining (mean ± SE; n = 3 with 50-75 cells per group per experiment; * p < 0.01 for the difference between control and Mn-treated groups after exposure to STx1). Note that treatment with Mn by itself did not affect cell viability. B. Mn exposure for periods used in STx1-viability assays does not affect cell viability assayed using MTT. To confirm that exposure to Mn for periods used in the STx1-viability assays did not compromise viability, HeLa cells were treated with or without 500 µM Mn for 4 h followed by 125 µM for an additional 24 h. Viability was then assessed using MTT (n = 3, p > 0.05).
